SCHEMBL25755675

SCHEMBL25755675

CC(C)CC(=O)OCCCl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PRKCA P17252 2/20 0.37
CA2 P00918 1/20 0.36
DPP4 P27487 1/20 0.35
KMT2A Q03164 1/20 0.34
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18378814 0.85 MMP1 (0.46) MMP1MMP2MMP3MMP9MMP13
SCHEMBL27650653 0.84 TSHR (0.36) ALDH1A1PRKCAKMT2ACYP2C19
SCHEMBL31112905 0.84 NAAA (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL698060 0.81
SCHEMBL11022032 0.81 ELANE (0.37) KMT2A
SCHEMBL113763 0.79 CYP19A1 (0.49) MMP1MMP2MMP3MMP9MMP13
SCHEMBL901332 0.79 CYP19A1 (0.49) MMP1MMP2MMP3MMP9MMP13
SCHEMBL7630194 0.79 MMP1 (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL7631813 0.79 MMP1 (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL133737 0.79 MMP1 (0.42) MMP1MMP2MMP3MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
WO-2024226691-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. (US) 2024-10-31 WO disclosed
US-20230276792-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND CLOQUINTOCET-MEXYL BAYER AKTIENGESELLSCHAFT (DE) 2023-09-07 US disclosed
US-20230217926-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND ISOXADIFEN-ETHYL BAYER AKTIENGESELLSCHAFT (DE) 2023-07-13 US disclosed
US-20230200390-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND MEFENPYR-DIETHYL BAYER AKTIENGESELLSCHAFT (DE) 2023-06-29 US disclosed
US-20230200394-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND BENOXACOR BAYER AKTIENGESELLSCHAFT (DE) 2023-06-29 US disclosed
US-20230200393-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND METCAMIFEN BAYER AKTIENGESELLSCHAFT (DE) 2023-06-29 US disclosed
US-20230189808-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND FURILAZOLE BAYER AKTIENGESELLSCHAFT (DE) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200394-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND BENOXACOR AADAC, CBR3, BROX MMP1 2092/4885MMP2 1886/4885MMP3 2387/4885
US-20230276792-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND CLOQUINTOCET-MEXYL AADAC, ABAT, ABCG2 MMP1 3507/4885MMP2 3284/4885MMP3 3521/4885
US-20230217926-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND ISOXADIFEN-ETHYL AADAC, CYP4F12, IDH2 MMP1 2609/4885MMP2 2183/4885MMP3 3297/4885
US-20230200393-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND METCAMIFEN MET, MTX2, AADAC MMP1 1096/4885MMP2 750/4885MMP3 1274/4885
US-20230200390-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND MEFENPYR-DIETHYL DDT, AADAC, EFHD2 MMP1 2315/4885MMP2 2116/4885MMP3 2636/4885
US-20230189808-A1 SELECTIVE HERBICIDES BASED ON SUBSTITUTED ISOXAZOLIN CARBOXAMIDES AND FURILAZOLE AADAC, NOTUM, CYP4X1 MMP1 1589/4885MMP2 2009/4885MMP3 2639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.